Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Kyprolis
Pharma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Both J&J's Darzalex and Sanofi's Sarclisa showed strong efficacy in newly diagnosed myeloma, but only one result is considered practice-changing.
Angus Liu
Dec 12, 2023 12:00pm
Sanofi's Sarclisa keeps pressure on J&J's Darzalex with new nod
Apr 2, 2021 10:53am
J&J's Darzalex, Amgen's Kyprolis join forces with new myeloma OK
Aug 21, 2020 11:21am
Sanofi takes aim at J&J's Darzalex with Sarclisa myeloma win
May 12, 2020 11:05am
Amgen bets on BeiGene's fast-growing sales force in China
Jan 3, 2020 10:40am
Amgen's Kyprolis, J&J's Darzalex team up on myeloma survival win
Sep 16, 2019 6:57am
